Indo US Bio-Tech Ltd.

NSE: INDOUS | BSE: 541304

₹97.99

up-down-arrow0.29 (0.30%)

As on 08-Jun-2026 10:50IST

Market cap

info icon

₹196 Cr

Revenue (TTM)

info icon

₹110 Cr

P/E Ratio

info icon

14.9

P/B Ratio

info icon

2.1

Div. Yield

info icon

0 %

Indo Us Bio-Tech Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 95.00 High: 99.94

52 Week Range

Low: 94.82 High: 206.00

Liquidityliquidity Moderate

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹13 Cr

  • ROEROE information

    23 %

  • ROCEROCE information

    21.1 %

  • Industry P/EIndustry P/E information

    14.9

  • EV/EBITDAEV/EBITDA information

    13.3

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹46.1

  • EPSEPS information

    ₹6.5

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    20,052,000

10 Years Aggregate

CFO

₹-7.18 Cr

EBITDA

₹63.06 Cr

Net Profit

₹48.55 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Indo Us Bio-Tech
-19.4 -13.0 -13.6 -40.1 -- -- --
BSE FMCG
-11.0 -5.5 -1.9 -12.4 -1.0 6.3 8.0
As on 08-Jun-2026
Company
2025
Indo Us Bio-Tech
-59.4
BSE Small Cap
-6.6
BSE FMCG
-2.1

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Indo Us Bio-Tech
98.0 195.7 110.4 13.1 14.6 14.6 14.9 2.1
119.6 1,249.9 2,001.7 60.8 -- 17.6 12.1 0.9
274.9 1,389.3 1,439.6 114.8 10.6 14.4 12.1 1.7
150.3 3,152.7 1,769.2 76.0 4.9 13.9 42.4 5.3
855.1 4,408.3 1,394.8 295.8 19.8 16.7 14.9 2.5
376.7 13,357.1 10,945.6 619.5 8.3 14.4 21.4 3.0
4.0 434.3 1,139.6 259.7 23.1 21 1.6 0.3
166.5 321.8 445.1 41.6 10.9 5.6 7.7 0.5
290.8 322.8 17.8 0.3 1.6 4.7 1079.6 46.6
3.7 463.5 1,345.6 31.8 4.8 6.8 14.6 1.0

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Indo Us Bio-Tech

Manufacture of food products

  • Incorporated

    2004

  • Chairman

    --

  • Managing Director

    Jagdish Ajudia

  • Headquarters

    Ahmedabad, Gujarat

  • Website

    www.indousagriseeds.com

Edit peer-selector-edit

FAQs for Indo Us Bio-Tech

The share price of Indo US Bio-Tech Ltd is ₹97.99 (NSE) and ₹99.65 (BSE) as of 08-Jun-2026 10:50 IST. Indo US Bio-Tech Ltd has given a return of -40.05% in the last 1 years.

The P/E ratio of Indo US Bio-Tech Ltd is 14.91 times as on 05-Jun-2026, a 0 premium to its peers’ median range of 14.90 times.
The P/B ratio of Indo US Bio-Tech Ltd is 2.12 times as on 05-Jun-2026, a 18 premium to its peers’ median range of 1.79 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
18.15
3.76
2024
53.94
7.09
2023
14.71
3.91
2022
12.22
1.61
2021
3.36
0.93

The 52-week high and low of Indo US Bio-Tech Ltd are Rs 206.00 and Rs 94.82 as of 08-Jun-2026.

Indo US Bio-Tech Ltd has a market capitalisation of ₹ 196 Cr as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Indo US Bio-Tech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.